George Simeon's Form 4 filing
Zenas BioPharma, Inc. (ZBIO) · filed Oct 14, 2025
- Accession no.
- 0001193125-25-239153
- Filed
- Oct 14, 2025, 5:14 PM ET
- Trade date
- Oct 9, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $2.40M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| George SimeonCIK 0001595117 | 10% Owner |
| Sr One Capital Management, LLCCIK 0001853723 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | Common Stock | PPurchaseAcquired | +63,158 | $19.00 | +$1,200,002 | 1,173,395 | Indirect | |
| Oct 9, 2025 | Common Stock | PPurchaseAcquired | +63,157 | $19.00 | +$1,199,983 | 1,917,895 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.